Endocrine disruptors (EDs) are chemical substances capable of altering hormonal balance through various mechanisms, such as steroidogenesis [1]. The H295R steroidogenesis assay described in OECD Test Guideline 456 [2] is a widely used in vitro tool to identify these compounds, but it measures only testosterone and estradiol. A broader analytical method covering the full set of steroids secreted by H295R cells is therefore needed, offering a more complete assessment of effects on steroid biosynthesis. In this work, we aimed to expand the assay to the simultaneous analysis of a panel of structurally related steroids.

An ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS) method was developed and optimized to separate, identify and quantify 18 steroids involved in human steroidogenesis, plus two internal standards, in a single injection. Because analytes are quantified directly in cell culture medium, sample preparation by solid-phase extraction (SPE) was optimized in parallel by testing different extraction conditions. Recoveries exceeded 80% for most analytes, with effective sample cleanup and improved method robustness.

Its applicability was confirmed employing reference compounds with known effects on steroid production, which gave concentration-dependent profiles. Suspected EDs present in environmental pollutants or used in industry also altered hormone secretion patterns, and the method distinguished inducers from inhibitors across the steroid panel.

In conclusion, the developed UHPLC-MS/MS method, combined with optimized SPE sample preparation, provides the analytical basis for the expanded H295R steroidogenesis assay, currently under validation in the OECD TG Programme [3], and is a suitable platform for characterizing compounds that affect steroid biosynthesis in drug discovery and toxicology.

Abstract

Poster